Epidermal growth factor receptor tyrosine kinase inhibitor in treatment of brain metastasis from non-small cell lung cancer

被引：0
|
作者：
Zhang, Lan-jun [1 ]
Cai, Ling [1 ]
Zhu, Jian-fei [1 ]
Rong, Tie-hua [1 ]
Wu, Shao-xiong [1 ]
Chen, Zhong-pin [1 ]
Liu, Meng-zhong [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18121
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Management of non-small cell lung cancer with resistance to epidermal growth factor receptor tyrosine kinase inhibitor: case discussion
    Zheng, Yuyan
    Zhou, Min
    Arulananda, Surein
    Um, Sang-Won
    Li, Hecheng
    JOURNAL OF THORACIC DISEASE, 2020, 12 (03) : 159 - 164
  • [22] Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer
    Kurihara, Eisuke
    Shien, Kazuhiko
    Torigoe, Hidejiro
    Takeda, Tatsuaki
    Takahashi, Yuta
    Ogoshi, Yusuke
    Yoshioka, Takahiro
    Namba, Kei
    Sato, Hiroki
    Suzawa, Ken
    Yamamoto, Hiromasa
    Soh, Junichi
    Okazaki, Mikio
    Shien, Tadahiko
    Tomida, Shuta
    Toyooka, Shinichi
    ANTICANCER RESEARCH, 2019, 39 (04) : 1767 - 1775
  • [23] Histological transformation from non-small cell to small cell lung carcinoma after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor
    Kim, Woo-Jin
    Kim, Sunmin
    Choi, Hayoung
    Chang, Jinsun
    Shin, Hong-Joon
    Park, Cheol-Kyu
    Oh, In-Jae
    Kim, Kyu-Sik
    Kim, Young-Chul
    Choi, Yoo-Duk
    THORACIC CANCER, 2015, 6 (06) : 800 - 804
  • [24] A FEASIBILITY OF CONCURRENT WHOLE BRAIN RADIATION PLUS EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITOR FOR NON-SMALL CELL LUNG CANCER
    Inamasu, Eiko
    Toyokawa, Gouji
    Shiraishi, Yoshimasa
    Morodomi, Yosuke
    Takenaka, Tomohiro
    Hirai, Yoshimitsu
    Yamaguchi, Ivlasahumi
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S479 - S479
  • [25] Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer
    Cascone, T
    Morelli, MP
    Ciardiello, F
    ANNALS OF ONCOLOGY, 2006, 17 : 46 - 48
  • [26] Combined therapy with epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
    Iwama, Eiji
    Nakanishi, Yoichi
    Okamoto, Isamu
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (03) : 267 - 276
  • [27] Epidermal growth factor receptor tyrosine kinase inhibitors in elderly patients with non-small cell lung cancer
    Zaarour, Mazen
    Weerasinghe, Chanudi
    Nazha, Bassel
    Hassan, Samer
    Atallah, Jean-Paul
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (11) : 1327 - 1336
  • [28] Acquired resistance of non-small cell lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors
    Nurwidya, Fariz
    Takahashi, Fumiyuki
    Murakami, Akiko
    Kobayashi, Isao
    Kato, Motoyasu
    Shukuya, Takehito
    Tajima, Ken
    Shimada, Naoko
    Takahashi, Kazuhisa
    RESPIRATORY INVESTIGATION, 2014, 52 (02) : 82 - 91
  • [29] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib
    Morin-Ben Abdallah, Sami
    Hirsh, Vera
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [30] Third-generation epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
    Wright, Natalie M. Andrews
    Goss, Glenwood D.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S247 - S264
12345